Research we fund
We are excited to be funding some of the leading brain tumour researchers in the UK and around the world. Find out more about them, their work and their motivation below.
The field of neuro-oncology research is greatly varied, with over 130 different tumour types in existence. So, we fund researchers who each have different expertise. Our researchers are investigating how changes to our genes are linked to tumour development, how our immune system can be primed to attack tumour cells and how drugs can be developed which target the tumour cells only, among many other areas of research.
-
Hijacking an innate immune mechanism present in all malignant cells
-
Blocking Brain Tumour Growth by Targeting a Key Growth Factor
-
Blocking DNA Repair in Gliomas to Overcome Resistance
-
Clinical Trial of Cannabis Derivatives
-
Creating a roadmap for better, evidence-based support for children living with brain tumours
-
Detecting Tumour DNA in Blood Samples to Monitor Gliomas After Treatment
-
Enhancing engineered immune cells to treat paediatric brain tumours
-
Exploring How Cells from the Skull Can Help Brain Tumours Hide from the Immune System
-
Exploring the role of genetics on children’s quality of life
-
Exploring the use of “smart viruses” to treat glioblastoma
-
Fighting recurrent Glioblastomas with immunotherapy
-
Finding New Targets for Glioblastoma Immunotherapy Treatments
-
Growing model brains in the search for new treatments
-
How the Brainstem Microenvironment Shapes Gliomas in Children
-
Identifying unique protein markers in brain tumours to develop new immune-based treatments
-
Improving treatment options for children diagnosed with rare tumours of the central nervous system
-
Managing fatigue in children living with the effects of a brain tumour
-
Preventing Glioblastoma Recurrence Using a Post-surgery Drug Paste
-
Reprogramming immune cells for the treatment of ependymoma
-
Reprogramming immune cells to increase treatment options for glioma patients
-
Supporting children returning to school after a brain tumour
-
Targeting Identified Surface markers in Medulloblastoma with Immunotherapy
-
Targeting Meningioma through immune interactions
-
Targeting non-dividing cells in childhood high-grade tumours